Results 261 to 270 of about 5,752,243 (395)

Teclistamab-Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma. [PDF]

EJHaem
Quevedo-Salazar R, Yáñez-Reyes JM, González-López EE, Varela-Constantino A, Gómez-De León A, González-Leal XJ, Gómez-Almaguer D.   +6 more
europepmc   +1 more source

MAMDC2-AS1 Induces Cuproptosis in Relapsed and Refractory Multiple Myeloma. [PDF]

Cancer Rep (Hoboken)
Chen Y, Liu J, Zhu Y.
europepmc   +1 more source

Fate of 35S-Cystine in Multiple Myeloma

, 1960
E. Siegel, Bernard Sachs, Frank A. Graig
openalex   +2 more sources

Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma [PDF]

, 1970
Sydney E. Salmon, Beth A. Smith
openalex   +1 more source

Potential roles of antibodies with different classes in IgG4‐related diseases

Rheumatology &Autoimmunity, EarlyView.
This review discussed the common characteristics of different classes of antibodies and their potential corresponding unique mechanisms involved in immunoglobulin G4‐related disease. Abstract Immunoglobulin G4‐related disease (IgG4‐RD), first identified two decades ago, is an immune‐mediated pro‐inflammatory and profibrotic disease entity affecting ...
Ling Li, Shaozhe Cai, Shengyan Lin, Lin Bai, Zhihua Yu, Wei Sun, Lingli Dong   +6 more
wiley   +1 more source

The progression of multiple myeloma is regulated by LILRB1 via the GATA2-SAGE1 pathway. [PDF]

Br J Haematol
Chen C, Zhou X, Cao L, Yang W, Weng L, Yuan J, Zhou W, Yu Z, Zheng J.   +8 more
europepmc   +1 more source

A MULTIPLE MYELOMA IN AN INFANT THAT STIMULATED PRENATAL MAXILLARY MALIGNANCY

, 1961
Yasunobu Suzuki, Hirokata Iwai, Akira Takasaki, Toshiki Inoue, HIDEO KURAI   +4 more
openalex   +2 more sources

Multiple Forms of DNA Polymerase in Mouse Myeloma [PDF]

, 1974
Akio Matsukage, E. W. Bohn, Samuel H. Wilson   +2 more
openalex   +1 more source

Radiolabeled Nanogels: From Multimodality Imaging to Combination Therapy of Cancer

Small Science, EarlyView.
Nanogel refers to nanosized particles formed by physical or chemical crosslinking of polymers. Rational design and refinement of nanogel properties are imperative to unlock their full potential, ensuring tailored solutions for personalized cancer management. This review elucidates the transformative potential of radiolabeled nanogels in revolutionizing
Sanchita Ghosh, Weibo Cai, Rubel Chakravarty   +2 more
wiley   +1 more source

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Haematologica, 2014
Neha Korde, Mattias Carlsten, Min-Jung Lee, Alex Minter, Esther Tan, Mary Kwok, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Adriana Zingone, Rene Costello, Marcia Mulquin, Diamond Zuchlinski, Irina Maric, Katherine R. Calvo, Raul Braylan, Prashant Tembhare, Constance Yuan, Maryalice Stetler-Stevenson, Jane Trepel, Richard Childs, Ola Landgren   +22 more
doaj   +1 more source